Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06206174Phase 1/2Recruiting
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
Acute Lymphoblastic Leukemia, AdultAcute Myeloid LeukemiaHematologic Malignancy+2 more
PrincipalinvestigatorStart date: 2024-03-06

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jianxiang Wang, MD

Institute of Hematology & Blood Diseases Hospital, China

Similar
1 trials

Shared therapeutic areas:

Acute Lymphoblastic Leukemia, AdultLeukemia, Myeloid, AcuteHematologic Neoplasms+2 more

Worked with same sponsors:

Institute of Hematology & Blood Diseases Hospital, ChinaShenzhen TargetRx Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Myeloid, AcuteMyelodysplastic Syndromes+1 more
Similarity Score24%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsLeukemia, Myeloid, AcuteLymphoma, Non-Hodgkin+1 more
Similarity Score24%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsMyelodysplastic Syndromes
Similarity Score18%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms

Worked with same sponsors:

Institute of Hematology & Blood Diseases Hospital, China
Similarity Score18%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma, Non-HodgkinMyelodysplastic Syndromes
Similarity Score18%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcuteHematologic Neoplasms
Similarity Score18%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score12%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score12%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06206174Phase 1/2PrincipalInvestigator

TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies

Acute Lymphoblastic Leukemia, AdultAcute Myeloid LeukemiaHematologic Malignancy+2 more
Recruiting

All 1 trials loaded